Coherus Biosciences (CHRS)
NASDAQ:CHRS
Holding CHRS?
Track your performance easily

Coherus Biosciences (CHRS) Technical Analysis

1,341 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Coherus Biosciences’s (CHRS) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Coherus Biosciences is a Buy.
Coherus Biosciences’s (CHRS) 20-Day exponential moving average is 1.27, while Coherus Biosciences’s (CHRS) share price is $1.115, making it a Sell.
Coherus Biosciences’s (CHRS) 50-Day exponential moving average is 1.41, while Coherus Biosciences’s (CHRS) share price is $1.115, making it a Sell.

Coherus Biosciences (CHRS) Pivot Points

Sep 19, 2024, 11:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.87
0.95
0.99
1.07
1.11
1.19
1.23
Fibonacci
0.95
0.99
1.02
1.07
1.11
1.14
1.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Coherus Biosciences (CHRS) Moving Averages

Sep 19, 2024, 11:42 PM
Period
Simple
Exponential
MA5
1.15Sell
1.12Sell
MA10
1.23Sell
1.20Sell
MA20
1.30Sell
1.27Sell
MA50
1.42Sell
1.41Sell
MA100
1.63Sell
1.62Sell
MA200
2.01Sell
2.01Sell
Coherus Biosciences’s (CHRS) 10-Day exponential moving average is 1.20, while Coherus Biosciences’s (CHRS) share price is $1.115, making it a Sell.
Coherus Biosciences’s (CHRS) 100-Day exponential moving average is 1.62, while Coherus Biosciences’s (CHRS) share price is $1.115, making it a Sell.
Coherus Biosciences’s (CHRS) stock price is $1.115 and Coherus Biosciences’s (CHRS) 50-day simple moving average is 1.42, creating a Sell signal.
Coherus Biosciences’s (CHRS) stock price is $1.115 and Coherus Biosciences’s (CHRS) 100-day simple moving average is 1.63, creating a Sell signal.
Coherus Biosciences’s (CHRS) stock price is $1.115 and Coherus Biosciences’s (CHRS) 200-day simple moving average is 2.01, creating a Sell signal.

Coherus Biosciences (CHRS) Technical Indicators

Sep 19, 2024, 11:42 PM
Name
Value
Implied Action
RSI (14)
33.76
Neutral
STOCH (9,6)
9.99
Buy
STOCHRSI (14)
7.64
Buy
MACD (12,26)
-0.08
Buy
ADX (14)
15.30
Buy
Williams %R
-91.67
Buy
CCI (14)
-217.69
Buy
ATR (14)
0.12
-
Ultimate Oscillator
33.51
Neutral
ROC
-22.79
Sell
Coherus Biosciences’s (CHRS) Relative Strength Index (RSI) is 33.76, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Trend Strength Indicator (ADX) is 15.30, creating a Buy signal.
Coherus Biosciences’s (CHRS) Commodity Channel Index (CCI) is -217.69, creating a Buy signal.
Coherus Biosciences’s (CHRS) Price Rate of Change (ROC) is -22.79, creating a Sell signal.

FAQ

Is CHRS a Buy, Hold, or Sell?
Based on CHRS’s technical indicators, CHRS is a Sell.
    What is CHRS’s RSI (14)?
    CHRS’s RSI (14) is 33.76, which suggests CHRS is a Neutral.
      What is CHRS’s MACD?
      CHRS’s MACD is -0.08, which suggests CHRS is a Buy.
        What is CHRS’s 5-day moving average?
        CHRS’s 5-day moving average is 1.15, which suggests CHRS is a Sell.
          What is CHRS’s 20-day moving average?
          CHRS 20-day moving average is 1.30, which suggests CHRS is a Sell.
            What is CHRS’s 50-day moving average?
            CHRS’s 50-day moving average is 1.42, which suggests CHRS is a Sell.
              What is CHRS’s 200-day moving average?
              CHRS’s 200-day moving average is 2.01, which suggests CHRS is a Sell.
                What is CHRS’s Williams % R (14)?
                CHRS’s Williams % R (14) is -91.67, which suggests CHRS is a Buy.
                  What is CHRS’s CCI (14)?
                  CHRS’s CCI (14) is -217.69, which suggests CHRS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis